Skip to main content
Erschienen in: Supportive Care in Cancer 4/2005

01.04.2005 | Original Article

Comparison of proposed diagnostic criteria with FACT-F and VAS for cancer-related fatigue: proposal for use as a screening tool

verfasst von: Simon Van Belle, Robert Paridaens, Georges Evers, Joseph Kerger, Dominique Bron, Jan Foubert, Gerrit Ponnet, Didier Vander Steichel, Christine Heremans, Dominique Rosillon

Erschienen in: Supportive Care in Cancer | Ausgabe 4/2005

Einloggen, um Zugang zu erhalten

Abstract

The objective was to validate the use of the proposed International Statistical Classification of Diseases and Related Health Problems (10th revision) (ICD-10) criteria for fatigue (P-ICD10) through comparison with the Functional Assessment of Cancer Therapy Fatigue (FACT-F) subscale and three visual analogue scale (VAS) qualities in cancer patients thought to be fatigued. Fatigue was assessed in 834 cancer patients at three clinical centres in Belgium, using P-ICD10, FACT-F, and VAS to assess: level of energy (VAS1), quality of life (VAS2), and ability to perform daily activities (VAS3). Of the 834 interviewed cancer patients, 54% were classified as fatigued by the P-ICD10 criteria. Internal consistency of P-ICD10 was very good (alpha coefficient 0.82). The principal component analysis corroborated good internal consistency with all variables included in the first component; a second component was used to identify psychological fatigue (concentration and short-term memory disabilities). An abridged set of screening tools based on the first three general symptoms of the P-ICD10 is proposed with 100% specificity and 86% specificity, respectively. There was a marked decrease in FACT-F and VAS1 scores in patients diagnosed as fatigued by the P-ICD10 (mean±SD, FACT-F 20±9 vs 39±8, VAS1 34±21 vs 61±21). A logistic regression model between P-ICD10 criteria diagnosis and FACT-F (VAS1) identified a score of 34 (61) on the FACT-F scale as a proposed cut-off point for the diagnosis of fatigue. The ICD-10 criteria can be recommended as a diagnostic tool, whereas the FACT-F scale and the level of energy 100-mm VAS assess the intensity of fatigue, and are more suitable for follow-up of cancer-related fatigue.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Miaskowski C, Portenoy RK (1998) Update on the assessment and management of cancer related fatigue. In: Berger AM, Portenoy RK, Weissman DE (eds) Principles and practice of supportive oncology updates. Lippincott Williams & Wilkins, Philadelphia, pp 1–10 Miaskowski C, Portenoy RK (1998) Update on the assessment and management of cancer related fatigue. In: Berger AM, Portenoy RK, Weissman DE (eds) Principles and practice of supportive oncology updates. Lippincott Williams & Wilkins, Philadelphia, pp 1–10
2.
Zurück zum Zitat Irvine DM, Vincent L, Bubela N, Thompson L, Graydon J (1991) A critical appraisal of the research literature investigating fatigue in the individual with cancer. Cancer Nurs 14:188–199PubMed Irvine DM, Vincent L, Bubela N, Thompson L, Graydon J (1991) A critical appraisal of the research literature investigating fatigue in the individual with cancer. Cancer Nurs 14:188–199PubMed
3.
Zurück zum Zitat Vogelzang NJ, Breitbart W, Cella D, et al (1997) Patient, caregiver and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. Semin Hematol 34 [Suppl 2]:4–12 Vogelzang NJ, Breitbart W, Cella D, et al (1997) Patient, caregiver and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. Semin Hematol 34 [Suppl 2]:4–12
4.
Zurück zum Zitat Detmar SB, Aaronson NK, Wever LD, Muller M, Schornagel JH (2000) How are you feeling? Who wants to know? Patients’ and oncologists’ preferences for discussing health-related quality-of-life issues. J Clin Oncol 18:3295–3301PubMed Detmar SB, Aaronson NK, Wever LD, Muller M, Schornagel JH (2000) How are you feeling? Who wants to know? Patients’ and oncologists’ preferences for discussing health-related quality-of-life issues. J Clin Oncol 18:3295–3301PubMed
5.
Zurück zum Zitat Costantini M, Mencaglia E, Giulio PD, et al (2000) Cancer patients as ‘experts’ in defining quality of life domains. A multicentre survey by the Italian Group for the Evaluation of Outcomes in Oncology (IGEO). Qual Life Res 9:151–159CrossRefPubMed Costantini M, Mencaglia E, Giulio PD, et al (2000) Cancer patients as ‘experts’ in defining quality of life domains. A multicentre survey by the Italian Group for the Evaluation of Outcomes in Oncology (IGEO). Qual Life Res 9:151–159CrossRefPubMed
6.
Zurück zum Zitat Cella D, Lai JS, Chang CH, Peterman A, Slavin M (2002) Fatigue in cancer patients compared with fatigue in the general United States population. Cancer 94:528–538CrossRefPubMed Cella D, Lai JS, Chang CH, Peterman A, Slavin M (2002) Fatigue in cancer patients compared with fatigue in the general United States population. Cancer 94:528–538CrossRefPubMed
7.
Zurück zum Zitat Curt GA (2000) Impact of fatigue in quality of life in oncology patients. Semin Hematol 37 [Suppl 6]:14–17 Curt GA (2000) Impact of fatigue in quality of life in oncology patients. Semin Hematol 37 [Suppl 6]:14–17
8.
Zurück zum Zitat Curt GA (2000) The impact of fatigue on patients with cancer: overview of FATIGUE 1 and 2. Oncologist 5 [Suppl 2]:9–12 Curt GA (2000) The impact of fatigue on patients with cancer: overview of FATIGUE 1 and 2. Oncologist 5 [Suppl 2]:9–12
9.
Zurück zum Zitat Curt GA, Breitbart W, Cella D, et al (2000) Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. Oncologist 5:353–360CrossRefPubMed Curt GA, Breitbart W, Cella D, et al (2000) Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. Oncologist 5:353–360CrossRefPubMed
10.
Zurück zum Zitat Ahlberg K, Ekman T, Gaston-Johansson F, Mock V (2003) Assessment and management of cancer-related fatigue in adults. Lancet 362:640–650CrossRefPubMed Ahlberg K, Ekman T, Gaston-Johansson F, Mock V (2003) Assessment and management of cancer-related fatigue in adults. Lancet 362:640–650CrossRefPubMed
11.
Zurück zum Zitat Gall H (1996) The basis of cancer fatigue: where does it come from? Eur J Cancer Care [Suppl] 5:31–34 Gall H (1996) The basis of cancer fatigue: where does it come from? Eur J Cancer Care [Suppl] 5:31–34
12.
Zurück zum Zitat Winningham ML, Nail LM, Burke MB, et al (1994) Fatigue and the cancer experience: the state of the knowledge. Oncol Nurs Forum 21:23–36PubMed Winningham ML, Nail LM, Burke MB, et al (1994) Fatigue and the cancer experience: the state of the knowledge. Oncol Nurs Forum 21:23–36PubMed
13.
Zurück zum Zitat World Health Organization (1992) International statistical classification of diseases and related health problems, 1989 revision (pre-release draft, June 2003). World Health Organization, Geneva World Health Organization (1992) International statistical classification of diseases and related health problems, 1989 revision (pre-release draft, June 2003). World Health Organization, Geneva
14.
Zurück zum Zitat National Cancer Institute (2004) Coping with cancer-fatigue (Fatigue PDQ(r) Guidelines). http://cancer.gov/cancerinfo/pdq/supportivecare/fatigue/healthprofessional. Accessed 20 April 2004 National Cancer Institute (2004) Coping with cancer-fatigue (Fatigue PDQ(r) Guidelines). http://​cancer.​gov/​cancerinfo/​pdq/​supportivecare/​fatigue/​healthprofession​al.​ Accessed 20 April 2004
15.
Zurück zum Zitat Portenoy RK, Miaskowski C (1998) Assessment and management of cancer-related fatigue. In: Berger AM, Portenoy RK, Weissman DE (eds) Principles and practice of supportive oncology. Lippincott-Williams & Wilkins, Philadelphia, pp 109–118 Portenoy RK, Miaskowski C (1998) Assessment and management of cancer-related fatigue. In: Berger AM, Portenoy RK, Weissman DE (eds) Principles and practice of supportive oncology. Lippincott-Williams & Wilkins, Philadelphia, pp 109–118
16.
Zurück zum Zitat Cella D, Peterman A, Passik S, Jacobsen P, Breitbart W (1998) Progress toward guidelines for the management of fatigue. Oncology (Huntingt) 12:369–377 Cella D, Peterman A, Passik S, Jacobsen P, Breitbart W (1998) Progress toward guidelines for the management of fatigue. Oncology (Huntingt) 12:369–377
17.
Zurück zum Zitat Centers for Disease Control (2003) International classification of diseases, 10th revision. Clinical modification (ICD-10-CM) (pre-release draft, June 2003). National Center for Heath Statistic. http://www.cdc.gov/nchs/about/otheract/icd9/icd10 cm.htm. Accessed 9 September 2003 Centers for Disease Control (2003) International classification of diseases, 10th revision. Clinical modification (ICD-10-CM) (pre-release draft, June 2003). National Center for Heath Statistic. http://​www.​cdc.​gov/​nchs/​about/​otheract/​icd9/​icd10 cm.htm. Accessed 9 September 2003
18.
Zurück zum Zitat Portenoy RK, Itri LM (1999) Cancer-related fatigue: guidelines for evaluation and management. Oncologist 4:1–10PubMed Portenoy RK, Itri LM (1999) Cancer-related fatigue: guidelines for evaluation and management. Oncologist 4:1–10PubMed
19.
Zurück zum Zitat Cella DF, Tulsky DS, Gray G, et al (1993) The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 11:570–579PubMed Cella DF, Tulsky DS, Gray G, et al (1993) The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 11:570–579PubMed
20.
Zurück zum Zitat Yellen S, Cella D, Webster K, Blendowski C, Kaplan E (1997) Measuring fatigue and other anemia-related symptoms in the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage 13:63–74CrossRefPubMed Yellen S, Cella D, Webster K, Blendowski C, Kaplan E (1997) Measuring fatigue and other anemia-related symptoms in the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage 13:63–74CrossRefPubMed
21.
Zurück zum Zitat Cronbach LJ (1951) Coefficient alpha and the internal structure of tests. Psychometrika 16:297–334 Cronbach LJ (1951) Coefficient alpha and the internal structure of tests. Psychometrika 16:297–334
22.
Zurück zum Zitat Cella D (1998) Factors influencing quality of life in cancer patients: anemia and fatigue. Semin Oncol 25 [Suppl 7]:43–46 Cella D (1998) Factors influencing quality of life in cancer patients: anemia and fatigue. Semin Oncol 25 [Suppl 7]:43–46
23.
Zurück zum Zitat Stein KD, Tomlin RL, Cole BT (2001) Assessment and management of cancer-related fatigue? Home Health Consult 8:8–15 Stein KD, Tomlin RL, Cole BT (2001) Assessment and management of cancer-related fatigue? Home Health Consult 8:8–15
24.
Zurück zum Zitat Miller M, Kearney N (2001) Nurses’ knowledge and attitudes towards cancer-related fatigue. Eur J Oncol Nurs 5:208–217; discussion 218–220CrossRefPubMed Miller M, Kearney N (2001) Nurses’ knowledge and attitudes towards cancer-related fatigue. Eur J Oncol Nurs 5:208–217; discussion 218–220CrossRefPubMed
25.
Zurück zum Zitat Hwang SS, Chang VT, Kasimis BS (2003) A comparison of three fatigue measures in veterans with cancer. Cancer Invest 21:363–373CrossRefPubMed Hwang SS, Chang VT, Kasimis BS (2003) A comparison of three fatigue measures in veterans with cancer. Cancer Invest 21:363–373CrossRefPubMed
26.
Zurück zum Zitat Wu HS, McSweeney M (2001) Measurement of fatigue in people with cancer. Oncol Nurs Forum 28:1371–1386PubMed Wu HS, McSweeney M (2001) Measurement of fatigue in people with cancer. Oncol Nurs Forum 28:1371–1386PubMed
27.
Zurück zum Zitat Tchekmedyian NS, Kallich J, McDermott A, Fayers P, Erder MH (2000) The relationship between psychologic distress and cancer-related fatigue. Cancer 98:198–203CrossRef Tchekmedyian NS, Kallich J, McDermott A, Fayers P, Erder MH (2000) The relationship between psychologic distress and cancer-related fatigue. Cancer 98:198–203CrossRef
28.
Zurück zum Zitat Sadler IJ, Jacobsen PB, Booth-Jones M, et al (2002) Preliminary evaluation of a clinical syndrome approach to assessing cancer-related fatigue. J Pain Symptom Manage 23:406–416CrossRefPubMed Sadler IJ, Jacobsen PB, Booth-Jones M, et al (2002) Preliminary evaluation of a clinical syndrome approach to assessing cancer-related fatigue. J Pain Symptom Manage 23:406–416CrossRefPubMed
29.
Zurück zum Zitat Mock V, Atkinson A, Barsevick A, et al (2000) NCCN practice guidelines for cancer-related fatigue. Oncology (Huntingt) 14:151–161 Mock V, Atkinson A, Barsevick A, et al (2000) NCCN practice guidelines for cancer-related fatigue. Oncology (Huntingt) 14:151–161
Metadaten
Titel
Comparison of proposed diagnostic criteria with FACT-F and VAS for cancer-related fatigue: proposal for use as a screening tool
verfasst von
Simon Van Belle
Robert Paridaens
Georges Evers
Joseph Kerger
Dominique Bron
Jan Foubert
Gerrit Ponnet
Didier Vander Steichel
Christine Heremans
Dominique Rosillon
Publikationsdatum
01.04.2005
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 4/2005
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-004-0734-y

Weitere Artikel der Ausgabe 4/2005

Supportive Care in Cancer 4/2005 Zur Ausgabe

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.